{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:32:26Z","timestamp":1791973946522,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-39","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T08:14:46Z","timestamp":1329293686000},"source":"Crossref","is-referenced-by-count":44,"title":["Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study"],"prefix":"10.1186","volume":"12","author":[{"given":"John A","family":"Joska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Westgarth-Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Hoare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin GF","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,15]]},"reference":[{"issue":"3","key":"1892_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S1355617700000230","volume":"1","author":"RK Heaton","year":"1995","unstructured":"Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, et al: The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995, 1 (3): 231-251. 10.1017\/S1355617700000230.","journal-title":"J Int Neuropsychol Soc"},{"issue":"11","key":"1892_CR2","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/00005072-199911000-00005","volume":"58","author":"SF An","year":"1999","unstructured":"An SF, Groves M, Gray F, Scaravilli F: Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol. 1999, 58 (11): 1156-1162. 10.1097\/00005072-199911000-00005.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1892_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/13550280290049615","volume":"8","author":"N Sacktor","year":"2002","unstructured":"Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, et al: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002, 8 (2): 136-142. 10.1080\/13550280290049615.","journal-title":"J Neurovirol"},{"issue":"2","key":"1892_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","volume":"19","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Brew BJ: Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev. 2009, 19 (2): 169-185. 10.1007\/s11065-009-9092-3.","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"1892_CR5","first-page":"94","volume":"16","author":"DB Clifford","year":"2008","unstructured":"Clifford DB: HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med. 2008, 16 (2): 94-98.","journal-title":"Top HIV Med"},{"issue":"14","key":"1892_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","volume":"25","author":"RJ Ellis","year":"2011","unstructured":"Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, et al: CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011, 25 (14): 1747-1751. 10.1097\/QAD.0b013e32834a40cd.","journal-title":"AIDS"},{"issue":"4","key":"1892_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13550280701422383","volume":"13","author":"KJ Liner","year":"2007","unstructured":"Liner KJ, Hall CD, Robertson KR: Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J Neurovirol. 2007, 13 (4): 291-304. 10.1080\/13550280701422383.","journal-title":"J Neurovirol"},{"issue":"3","key":"1892_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ana.21292","volume":"63","author":"M Mishra","year":"2008","unstructured":"Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P: Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol. 2008, 63 (3): 366-376. 10.1002\/ana.21292.","journal-title":"Ann Neurol"},{"issue":"3","key":"1892_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/13550280701258407","volume":"13","author":"JD Gupta","year":"2007","unstructured":"Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, et al: Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol. 2007, 13 (3): 195-202. 10.1080\/13550280701258407.","journal-title":"J Neurovirol"},{"issue":"2","key":"1892_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10461-009-9538-x","volume":"14","author":"JA Joska","year":"2010","unstructured":"Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S: Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav. 2010, 14 (2): 371-8. 10.1007\/s10461-009-9538-x.","journal-title":"AIDS Behav"},{"issue":"14","key":"1892_CR11","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","volume":"21","author":"KR Robertson","year":"2007","unstructured":"Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al: The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007, 21 (14): 1915-1921. 10.1097\/QAD.0b013e32828e4e27.","journal-title":"AIDS"},{"key":"1892_CR12","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1212\/WNL.52.8.1640","volume":"52","author":"N Sacktor","year":"1999","unstructured":"Sacktor N, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, et al: Combination antiretroviral therapy improves psychomotor speed performance in HIV + homosexual men. Neurology. 1999, 52: 1640-1647.","journal-title":"Neurology"},{"issue":"4","key":"1892_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1212\/01.WNL.0000076477.71313.6E","volume":"61","author":"N Sacktor","year":"2003","unstructured":"Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, et al: Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology. 2003, 61 (4): 567-569.","journal-title":"Neurology"},{"issue":"1","key":"1892_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al: Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008, 65 (1): 65-70. 10.1001\/archneurol.2007.31.","journal-title":"Arch Neurol"},{"issue":"1","key":"1892_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/09540260701861930","volume":"20","author":"A Nath","year":"2008","unstructured":"Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J: Evolution of HIV dementia with HIV infection. Int Rev Psychiatry. 2008, 20 (1): 25-31. 10.1080\/09540260701861930.","journal-title":"Int Rev Psychiatry"},{"issue":"16","key":"1892_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","volume":"74","author":"KR Robertson","year":"2010","unstructured":"Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, et al: Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010, 74 (16): 1260-1266. 10.1212\/WNL.0b013e3181d9ed09.","journal-title":"Neurology"},{"issue":"3","key":"1892_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","volume":"25","author":"M Smurzynski","year":"2011","unstructured":"Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, et al: Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 2011, 25 (3): 357-365. 10.1097\/QAD.0b013e32834171f8.","journal-title":"AIDS"},{"issue":"5","key":"1892_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","volume":"73","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, et al: Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology. 2009, 73 (5): 342-348. 10.1212\/WNL.0b013e3181ab2b3b.","journal-title":"Neurology"},{"issue":"11","key":"1892_CR19","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","volume":"23","author":"CM Marra","year":"2009","unstructured":"Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, et al: Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009, 23 (11): 1359-1366. 10.1097\/QAD.0b013e32832c4152.","journal-title":"AIDS"},{"issue":"6","key":"1892_CR20","first-page":"1197","volume":"15","author":"JA Josk","year":"2011","unstructured":"Josk JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, et al: Characterization of HIV-Associated Neurocognitive Disorders Among Individuals Starting Antiretroviral Therapy in South Africa. AIDS Behav 2010. 2011, 15 (6): 1197-203.","journal-title":"AIDS Behav 2010"},{"issue":"12","key":"1892_CR21","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/jmv.20735","volume":"78","author":"GB Jacobs","year":"2006","unstructured":"Jacobs GB, de BC, Fincham JE, Adams V, Dhansay MA, van Rensburg EJ, et al: Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa. J Med Virol. 2006, 78 (12): 1529-1536. 10.1002\/jmv.20735.","journal-title":"J Med Virol"},{"issue":"3","key":"1892_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","volume":"5","author":"J Amin","year":"2004","unstructured":"Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ: HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 2004, 5 (3): 174-179. 10.1111\/j.1468-1293.2004.00207.x.","journal-title":"HIV Med"},{"issue":"3","key":"1892_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, et al: Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004, 26 (3): 307-319. 10.1080\/13803390490510031.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"10","key":"1892_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7326\/0003-4819-143-10-200511150-00008","volume":"143","author":"DB Clifford","year":"2005","unstructured":"Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Tashima K, et al: Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med. 2005, 143 (10): 714-721.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1892_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","volume":"19","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Brew BJ: Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev. 2009, 19 (2): 169-185. 10.1007\/s11065-009-9092-3.","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"1892_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","volume":"19","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Brew BJ: Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev. 2009, 19 (2): 169-185. 10.1007\/s11065-009-9092-3.","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"1892_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al: HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011, 17 (1): 3-16. 10.1007\/s13365-010-0006-1.","journal-title":"J Neurovirol"},{"issue":"2","key":"1892_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1176\/jnp.15.2.208","volume":"15","author":"SJ Ferrando","year":"2003","unstructured":"Ferrando SJ, Rabkin JG, Van GW, Lin SH, McElhiney M: Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. J Neuropsychiatry Clin Neurosci. 2003, 15 (2): 208-214. 10.1176\/appi.neuropsych.15.2.208.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"8","key":"1892_CR29","doi-asserted-by":"publisher","first-page":"F65","DOI":"10.1097\/00002030-199808000-00002","volume":"12","author":"S Ferrando","year":"1998","unstructured":"Ferrando S: Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS. 1998, 12 (8): F65-70. 10.1097\/00002030-199808000-00002.","journal-title":"AIDS"},{"issue":"1","key":"1892_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00126334-200405010-00003","volume":"36","author":"KR Robertson","year":"2004","unstructured":"Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, et al: Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr. 2004, 36 (1): 562-566. 10.1097\/00126334-200405010-00003.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"1892_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1212\/01.wnl.0000225183.74521.72","volume":"67","author":"N Sacktor","year":"2006","unstructured":"Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, et al: Antiretroviral therapy improves cognitive impairment in HIV + individuals in sub-Saharan Africa. Neurology. 2006, 67 (2): 311-314. 10.1212\/01.wnl.0000225183.74521.72.","journal-title":"Neurology"},{"issue":"1","key":"1892_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/09540260701877894","volume":"20","author":"I Grant","year":"2008","unstructured":"Grant I: Neurocognitive disturbances in HIV. Int Rev Psychiatry. 2008, 20 (1): 33-47. 10.1080\/09540260701877894.","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"1892_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1017\/S1355617799544068","volume":"5","author":"NR Temkin","year":"1999","unstructured":"Temkin NR, Heaton RK, Grant I, Dikmen SS: Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc. 1999, 5 (4): 357-369.","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"1892_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/13803390490510824","volume":"26","author":"AB Shuttleworth-Edwards","year":"2004","unstructured":"Shuttleworth-Edwards AB, Kemp RD, Rust AL, Muirhead JG, Hartman NP, Radloff SE: Cross-cultural effects on IQ test performance: a review and preliminary normative indications on WAIS-III test performance. J Clin Exp Neuropsychol. 2004, 26 (7): 903-920. 10.1080\/13803390490510824.","journal-title":"J Clin Exp Neuropsychol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:11:26Z","timestamp":1548202286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-39","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,15]]},"article-number":"39"}}